San Francisco, CA, USA, June 12, 2018 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license […]
Mouse Powered Progress: Producing Humanized Monoclonal Antibodies With Transgenic Mice
Antibodies are a critical feature of the human adaptive immune response. New immunotherapies require the production of selective and non-autoimmunogenic […]
Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement
San Francisco, CA, USA, March 28, 2018 – Trianni, Inc. (“TRIANNI”) and NovaRock Biotherapeutics, Ltd. (“NOVAROCK”) jointly announced today that […]
ENTHERA and TRIANNI Announce Licensing Agreement
San Francisco, CA, USA and Milano, Italy, March 22, 2018 – Trianni, Inc. (“TRIANNI”) and Enthera, S.r.l. (“ENTHERA”) jointly announced […]
TRIANNI sponsors The Werner Müller Award for Excellence in Immunology
San Francisco, CA, USA. and Berlin, Germany, December 6, 2017 –Trianni, Inc. (“TRIANNI”) announced that it will sponsor the Werner […]
Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform
San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”). today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]
TRIANNI Signs Agreement with Massachusetts General Hospital for Use of The Trianni Mouse™ in HIV Vaccine Research
San Francisco, CA, USA, June 1 2017 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into an agreement […]
TRIANNI and Olympic Protein Technologies Sign License Agreement for The Trianni Mouse™
San Francisco, CA and Seattle, WA, USA., May 24, 2017 –Trianni, Inc. (“TRIANNI”) and Olympic Protein Technologies (“Olympic”) jointly announced […]
Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™
Rockville, MD and San Francisco, CA, USA, May 18, 2017–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, and […]
TRIANNI Signs Agreement with Magenta Therapeutics for Use of The Trianni Mouse
San Francisco, CA, USA., March 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]
Recent Comments